UBE2V2P4

Across TCGA pan-cancer cohorts, UBE2V2P4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of UBE2V2P4’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where UBE2V2P4 RNA is repressed in tumor relative to normal tissue. In most cancer types UBE2V2P4 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and STAD are the cancer types where UBE2V2P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2V2P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	II,III,IV	−0.195	.009	3	view →
LUSC	Female	III,IV	−0.350	.003	1	view →
STAD	Male	All	+0.332	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

UBE2V2P4–LUAD

Open the LUAD breakdown →